Clinical Trial: Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study

U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07583511) titled 'Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study' on July 23, 2024.

Brief Summary: To compare the efficacy and safety between teniposide, cisplatin and serplulimab regimen and etoposide, cisplatin and serplulimab regimen in the treatment of extensive stage small lung cancer

Study Start Date: Feb. 01, 2024

Study Type: INTERVENTIONAL

Condition: Small-cell Lung Cancer

Intervention: DRUG: Teniposide

To evaluate the efficacy and safety of teniposide regimen

DRUG: Etoposide

For comparison

DRUG: serplulimab

Fixed regimen

DRUG: cisplatin

Fixed regimen

Recruitment Status: RECRUITING ...